Abstract:STUDY QUESTION: Does bone morphogenetic protein 2 (BMP2) regulate connexin43 (Cx43) and modulate cell-cell communication in luteinized human granulosa cells?SUMMARY ANSWER: BMP2 decreases gap junction intercellular communication (GJIC) of luteinized human granulosa cells by down-regulating Cx43 expression through an activin receptor-like kinase (ALK) 2/ALK3-mediated Sma- and Mad-related protein (SMAD)-dependent signaling pathway.WHAT IS KNOWN ALREADY: BMP2 and its putative receptors are highly expressed in the human corpus luteum and are involved in the process of luteolysis. Cx43-coupled gap junctions play a critical role in the development and maintenance of corpus luteum.STUDY DESIGN DURATION: This is a laboratory study conducted over a 1-year period. At least three independent experiments with three replicates were conducted and the experimental samples were compared with the appropriate vehicle controls for all of the inhibition-approach, concentration-dependent or time-course studies.PARTICIPANTS/MATERIALS, SETTING, METHODS: SVOG cell line (immortalized human granulosa-lutein cells derived from in vitro fertilization patients in an academic research center) was used as the study model. The changes of Cx43 expression and levels of phosphorylated SMAD1/5/8 protein were evaluated after exposure to recombinant human BMP2. Real-time quantitative PCR and Western blot analysis were used to examine the specific mRNA and protein levels, respectively. The BMP/TGF-beta type I receptor inhibitors (Dorsomorphin, DMH-1 and SB431542) and target depletion small interfering RNAs (ALK2, ALK3, ALK6 and SMAD4) were used to investigate the underlying molecular mechanisms. A scrape loading and dye transfer assay was used to evaluate the GJIC between the SVOG cells.MAIN RESULTS AND THE ROLE OF CHANCE: Treatment with BMP2 down-regulated the expression of Cx43 and decreased the GJIC activity, whereas it increased the phosphorylated SMAD1/5/8 protein in SVOG cells (P < 0.05). These biological effects were abolished by pretreatment with the BMP type I receptor inhibitors, Dorsomorphin and DMH-1 (P < 0.05), but not SB431542. Additionally, the individual or concomitant small interfering RNA-mediated knockdown of ALK2 and ALK3, but not ALK6 attenuated the BMP2-induced increases in phosphorylated SMAD1/5/8 and down-regulation of Cx43 expression (P < 0.05). The knockdown of SMAD4 completely abolished the BMP2-induced down-regulation of Cx43 expression (P < 0.05).LIMITATIONS REASONS FOR CAUTION: This experimental study was conducted in an in vitro cell culture system, and may not reflect a realistic intra-ovarian environment.WIDER IMPLICATIONS OF THE FINDINGS: Our results suggested that BMP2 may be involved in the local modulation of cell-cell communication in the luteal phase. This study also represents the first comprehensive research of molecular mechanisms of BMP2 in the down-regulation Cx43 in luteinized human granulosa cells. Such data may provide valuable insights into ovarian physiology and benefit the development of potential therapeutic methods for patients suffering from luteal insufficiency.LARGE SCALE DATA: N/A

Corticotropin-releasing Hormone Activates Connexin 43 Via Activator Protein-1 Transcription Factor in Human Myometrial Smooth Muscle Cells.

Expression changes of c-Fos and neuronal nitric oxide synthase in medullary visceral zone induced by varied distention of uterine cervicx

Impact of Axis of GHRH and GHRH Receptor on Cell Viability and Apoptosis of the Placental Choriocarcinoma Cell Line.

GnRH I and II up-regulate MMP-26 expression through the JNK pathway in human cytotrophoblasts

The integration of multiple signaling pathways provides for bidirectional control of CRHR1 gene transcription in rat pituitary cell during hypoxia.

Corticotropin releasing hormone modulates endotoxin-induced inflammatory cytokine expression in human trophoblast cells

Rapid membrane effect of estrogens on stimulation of corticotropin-releasing hormone

Crf Receptor Type 1 Mediates Continual Hypoxia-Induced Crf Peptide And Crf Mrna Expression Increase In Hypothalamic Pvn Of Rats

Corticotropin-releasing hormone receptor 1 coexists with endothelin-1 and modulates its mRNA expression and release in rat paraventricular nucleus during hypoxia.

Corticotropin-releasing Factor Receptor Type 1 Colocalizes with Type 2 in Corticotropin-Releasing Factor-Containing Cellular Profiles in Rat Brain.

Bone Morphogenetic Protein 2 Regulates Cell-Cell Communication by Down-Regulating Connexin43 Expression in Luteinized Human Granulosa Cells

Direct Effects of Inflammatory Cytokines on Mouse Uterine Contraction

The promoting role of Cx43 on the proliferation and migration of arterial smooth muscle cells for angiotensin II-dependent hypertension

Activation of the Epithelial Sodium Channel ( EN Ac) Leads to Cytokine Profile Shift to Pro‐inflammatory in Labor

Regulation of Gap-Junction Protein Connexin 43 by Β-Adrenergic Receptor Stimulation in Rat Cardiomyocytes

Oxytocin can regulate myometrial smooth muscle excitability by inhibiting the Na+ -activated K+ channel, Slo2.1

The Role of Formyl Peptide Receptor 1 in Uterine Contraction During Parturition

Phorbol Ester Treatment Of Human Myometrial Cells Suppresses Expression Of Oxytocin Receptor Through A Mechanism That Does Not Involve Activator Protein-1

[Scanning of drug targets related to uterus contraction from the uterine smooth muscles by cDNA microarray]

Corticotrophin-releasing factor type 2 receptor-mediated suppression of gonadotrophin-releasing hormone mRNA expression in GT1-7 cells

The heart: a novel gonadotrophin-releasing hormone target.